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The Past and the Future of Arthritis & Rheumatism
A View From the American College of Rheumatology
David A. Fox
The 50th anniversary of Arthritis & Rheumatism
(A&R) is an occasion to celebrate the successes of the
journal that is not only the flagship publication of the
American College of Rheumatology (ACR), but also of
the field of rheumatology internationally. This article
will consider the relationship of A&R to the College and
to rheumatology as a professional discipline, by looking
back to our origins and by reviewing the principles that
have helped A&R to grow, evolve, and thrive.
Issue 1 of volume 1, from February of 1958,
began with an essay by the Editor, William S. Clark (1),
and followed with a description of the history of the
American Rheumatism Association (ARA) by Robert
M. Stecher (2). Clark addressed the rationale for cre-
ation of this new journal, the scope of the disciplines it
would cover, and the process by which A&R had been
established. He laid out a broad scope for the fledgling
publication that included virtually all of what is now
considered to be clinical rheumatology, as well as re-
search in such areas as connective tissue biology and
immunology. Clark emphasized the need for A&R to
reflect a multidisciplinary approach to the rheumatic
diseases that involved clinicians and scientists. This
philosophy has been expanded over the past 5 decades,
and is reflected in the diverse professional backgrounds
of members of the ACR, as well as authors and readers
of articles published in A&R and in Arthritis Care &
Research.
The list of authors whose articles appeared in the
first volume of A&R includes many clinicians and labo-
ratory scientists who are well-recognized as founders of
the field of rheumatology in the United States—Richard
Freyberg, Currier McEwen, Morris Ziff, Alan Cohen,
Evan Calkins, Joseph Bunim, Howard Holley, John
Vaughan, James Wyngaarden, Mart Mannik, and nu-
merous others. It also includes several giants of the early
days of immunology research whose work helped to
establish the framework for our understanding of the
roles of autoantibodies and lymphocytes in rheumatic
diseases—Henry Kunkel, Robert Good, E.C. Franklin,
and Hugh Fudenberg.
The range of diseases and syndromes in the six
issues (588 pages) of volume 1 reflects much of the
breadth and diversity of the conditions that we aggregate
into the domain of rheumatology: rheumatoid arthritis,
osteoarthritis, gout, systemic lupus erythematosus, vas-
culitis, ankylosing spondylitis, inherited metabolic ar-
thropathies, rheumatic fever, and even sarcoidosis. (Al-
though there were no articles on bursitis, back pain, or
fibromyalgia.) The first volume also contained a few
reviews, editorials, letters to the editor, news from the
ARA (now the ACR), and abstracts that had been
presented at scientific meetings, complete with tran-
scriptions of questions and commentary from the audi-
ence.
The methodology and utility of laboratory tests—
especially rheumatoid factor and the LE cell
determination—were important areas of focus. Several
papers discussed complications of the drugs then in use
for arthritis, such as prednisone, gold salts, and phenyl-
butazone. Among the therapeutic reports was one con-
trolled trial on the use of chloroquine in rheumatoid
arthritis. Only a handful of papers or reviews addressed
issues such as the epidemiology of rheumatic diseases,
outcome measures, and rehabilitation. Often the em-
phasis was on what was as yet unknown, rather than on
what had just been discovered. For example, Sidney
Cobb wrote, concerning “rheumatoid disease,” “In
terms of estimates of incidence and prevalence, we can
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only say that to date we have no adequate estimates
. . . The field is wide open, for there are very few
physicians interested in this approach” (3).
I suspect that it will be a surprise to most of the
2008 readership of A&R that in the 1950s there was
considerable skepticism concerning the need for a new
journal such as A&R. Journals devoted to the rheumatic
diseases had already been established in many European
countries and in Argentina. The British journal Annals
of the Rheumatic Diseases was well respected, and many
prominent American rheumatologists felt that it should
become the official journal of the ARA. There was
concern that an insufficient number of high quality
articles would be submitted. Some felt that the develop-
ment of interest in rheumatic diseases would be better
served by publishing advances in the field in general
medical journals (4). A decade of debate, recommenda-
tions from committees, and surveys of the ARA mem-
bership were part of the tortuous gestation of A&R,
which continued until those who opposed the new
journal had retired from leadership positions in the
ARA! Among those who should be given credit for the
successful launch of A&R are the following four individ-
uals: Dr. Robert Stecher, who as President of the ARA
called for creation of a new journal in his presidential
address in 1948; Dr. Joseph Hollander, who chaired an
ARA committee that in 1954 recommended establish-
ment of the journal; the first Editor, Dr. William S.
Clark; and the first Chair of the Publications Committee,
Dr. Richard Freyberg.
The name “American Journal of Rheumatic Dis-
eases” was considered, but was rejected as too parochial.
It was hoped that the new journal would ultimately be
international in scope, although the first issue’s authors
were almost all from the United States. Abstracts of full
length articles were, however, printed in both English
and Spanish. Fifty years later, much of the readership of
A&R and a majority of the papers submitted to it are
from countries other than the United States. I doubt that
the first editor could have foreseen the extent to which
his vision of an international journal would have come to
fruition.
It is important to remember that in 1958 rheu-
matology was not a well-defined specialty, but was
instead a focus of interest for a subset of internists,
pediatricians, and other health care professionals. The
first board examinations that certified specially trained
physicians as rheumatologists were many years away—
not until 1972 did the first cohort of prospective rheu-
matologists pass their boards (5). In the absence of a
subspecialty board, it seems likely that A&R, along with
other journals, played a prominent and essential role in
establishing the dimensions and content of the field of
rheumatology. A specialized journal has the potential to
provide focus and unity within a field of medicine—in
the case of A&R it may have helped to actually create the
discipline of rheumatology in the United States.
Many of the principles that guide A&R today are
identical to those that were articulated when it was
founded. Among the most important is a commitment to
quality—the publication of the very best research rele-
vant to the rheumatic diseases. Quality is not solely a
standard to be demanded from the authors, but must
also be reflected in the work of the Editor, the reviewers,
and the production staff of the journal. When A&R was
founded, the Editorial Board of the new journal and the
ARA Publications Committee were a who’s-who of
luminaries in the field (Figure 1).
It seems that once A&R finally got going, there
was widespread agreement that it ought to succeed, a
consensus that has remained solid over its first half-
century. Editorship of A&R is arguably the most signif-
icant and prestigious position in the field of rheumatol-
ogy. The position is reassigned every 5 years and the
competition for this post is fierce. The selection of an
Editor is the most important task of the Publications
Committee, and is conducted in a process that is rigor-
ous and fair. The result has been a continuous succession
of outstanding Editors, who have brought the highest
level of talent and dedication to their role. These Editors
have, in turn, assembled Editorial Boards and rosters of
reviewers, international in scope, whose depth and
breadth of expertise is the best that rheumatology has to
offer.
What might be overlooked, except by authors
who have published a paper in A&R, is the contribution
of the editorial staff, led in recent decades by Jane
Diamond, to the quality and rigor of every article. The
production process not only corrects mistakes in spelling
and grammar, but also analyzes the content of every
paper in depth to assure consistency and accuracy.
Errors in figures and figure legends, or discrepancies
between the methods section of a paper and the figure
legends are identified and corrected before publication.
It is not an exaggeration to state that the production
standards of A&R are matched by few, if any, other
journals in biology or medicine.
Another principle, one that governs the relation-
ship between the ACR and A&R, is editorial indepen-
dence. It is the Editor, not the ACR or its officers, who
has control, absolute control, over what appears in the
pages of A&R. While oversight of the operations of A&R
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and its sibling Arthritis Care & Research is provided by
the Publications Committee, there is no meddling in the
month-to-month content. If the Editor wishes to expand
the number of pages, ACR approval is needed, but what
goes into those pages reflects the judgment of the
Editor, assisted by the Editorial Board. Independence of
the Editor also means that he or she must be free of
conflicts of interest, actual or perceived, so that A&R can
be legitimately viewed as an authoritative and unbiased
source of information and viewpoints on advances in
science and clinical medicine, as well as on issues that
may be controversial. The Editor of A&R is therefore
prohibited from a wide range of activities, such as service
as a consultant for pharmaceutical manufacturers, which
could impinge on his or her independence of judgment.
Professional conflict-of-interest standards have steadily
evolved over the past two decades to become more
stringent, and the Ethics Committee of the ACR acts as
a monitor of the integrity of the College, including its
journal Editors.
The ACR, like any professional organization,
frequently needs to communicate both with its members
Figure 1. Editorial Board and Publication Committee, 1958.
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and with a variety of other constituencies. One option
could be to use its scientific journals as communication
vehicles. The purposes of A&R are, however, to educate
its readers and to advance the science and practice of
rheumatology. These purposes would be diluted or
obscured by its use to communicate the position of the
ACR on topics such as pending legislation or regulations
that could impact physician reimbursement, notwith-
standing the importance of such matters to the member-
ship of the ACR. Therefore, topics of interest to ACR
members that appear in the pages of A&R are limited to
educational information—announcements about scien-
tific meetings and courses, for example. Other venues
serve the needs of the ACR and its members to com-
municate with each other about current professional
issues, including The Rheumatologist, a new publication
launched one year ago that is edited by former A&R
Editor David Pisetsky.
Elsewhere in this issue, the current A&R Editor,
Michael Lockshin, discusses the accelerating changes in
scientific publication, such as electronic publication and
open access journals. Each Editor of A&R has been an
innovator, altering the format of material published in
the journal. The electronic tools now at our disposal
should not be viewed as a threat, but rather as an
opportunity for A&R to expand the reach of its educa-
tional mission by increasing access and by being ever
more timely in up-dating knowledge in the field of
rheumatology. As the striking workforce deficiencies in
rheumatology become a focus for prompt action, we
should consider how A&R can educate trainees at all
levels, ranging from fellows who present articles in
journal clubs to medical students learning about rheu-
matology for the first time, and even to high school or
college students whose career directions are as yet
unformed. Instant electronic access to advances in rheu-
matology published in A&R, coupled with an explana-
tion or translation of these advances for the less special-
ized or sophisticated student, could be a way to spark
interest in a career as a rheumatologist, allied health
professional, or researcher.
A&R will never be replaced by a blog! Blogs can
provide information, which, if verifiable, can be viewed
as legitimate knowledge. A talented Editor, however,
can make sure that a great journal will impart not just
knowledge but also wisdom. Rheumatology has flour-
ished over the past 50 years because it has grown not just
in knowledge but also in wisdom. If we look to the future
with an open mind—and continue to recruit great
Editors for A&R—the progress of the next 50 years, and
the role of A&R in conveying, stimulating, and focusing
that progress will dwarf our past accomplishments.
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